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Summary Human tumour lines established in athymic nude mice were grafted under the renal capsule of
immunocompetent mice. Grafts from 27 human tumour lines comprising 9 malignant melanomas, 10
sarcomas, 2 colon carcinomas, 4 lung carcinomas and 2 mammary carcinomas, grew well under the renal
capsule of the immunocompetent mice and retained morphological and functional characteristics of the parent
tumours, as judged by light and electron microscopy and immunohistochemical examinations. Numerous
mitoses were detected. Granulation tissue and necrosis were not predominant features. After Day 4, the grafts
became infiltrated from the periphery by mouse inflammatory cells. The infiltration could be prevented by
pretreatment of the animals with cyclophosphamide. Anti-human antibodies were detected after Day 3.
Single cell suspensions from the subrenal grafts were able to form colonies in soft agar. and upon
reimplantation in nude mice, subcutaneous tumours were formed showing that the grafted tumour tissue had
also retained its malignant character. Altogether the results support the view that human tumour xenografts
grow well under the renal capsule of immunocompetent mice and that the grafts retain important
characteristics of the original tumour.
Human tumour xenografts have been widely used
for the purpose of assessing the responsiveness of
human tumours to chemotherapeutic agents
(Giovanella et al., 1974; Kopper & Steel, 1975;
Povisen & Jacobsen 1975; Fodstad et al., 1977;
Osieka et al., 1977; Ovejera et al., 1978; Giovanella
et al., 1983), and for evaluating the antineoplastic
activity of new anticancer drugs (Bellet et al., 1979;
Venditti, 1981). So far largely xenografts growing
subcutaneously in athymic or immunosuppressed
mice have been used. However, the procedures
involved are expensive and time consuming and
efforts have therefore been made to develop simpler
and more rapid in vivo methods.
During the last few years Bogden et al. (1978,
1979, 1981) have introduced a new procedure
involving the implantation of small, solid pieces of
human tumours under the renal capsule of normal.
conventional mice and evaluation 6 days later of
the graft response to treatment. This "6-day
subrenal capsule (SRC) assay" in immuno-
competent mice has been used on fresh surgical
explants to assess the response of individual human
tumours to chemotherapeutic agents (Griffin et al.,
1983), and to evaluate the anti-tumour activity of
new experimental drugs (Cobb et al., 1983).
The SRC assay has several favourable features. It
is fairly rapid and relatively inexpensive. However,
before the assay can be accepted as a routine
procedure several questions must be answered.
Thus, it is not clear whether the observed increases
in the size of the subrenal grafts are actually due to
proliferation of tumour cells and whether the grafts
retain their characteristics during growth under the
renal capsule. In fact, it has been reported (Seltzer
et al., 1983) that the observed increase in implant
size resulted from inflammation and oedema rather
than from tumour growth, and Edelstein et al.
(1983) found that most or part of the subrenal
grafts on Day 6 was replaced by granulation tissue
due to immune-mediated inflammation. In their
study no mitoses were observed and the residual
tumour cells showed signs of degeneration and
necrosis.
For methodological studies of the subrenal
capsule assay, human tumour xenografts, serially
transplanted in athymic, nude mice, possess several
advantages as a source of tumour tissue. Such
xenografts represent a constant and readily
available source of material that can be produced in
desired quantities. Importantly, in contrast to
patients' biopsies they permit the repetition of
experiments on the same fresh, previously untreated
tumour cells. We have studied the growth
properties of such subrenal grafts in a previous
paper (Aamdal et al., 1984b). The application and
usefulness of subrenal grafts for the purpose of
chemosensitivity measurements have been con-
sidered elsewhere (Aamdal et al., 1983a, 1984c,
1984d) and will be treated in more detail in a
forthcoming publication.
In the present paper the main question asked is
whether human tumours of different histological
types, grafted under the renal capsule of immuno-
competent mice contain viable, proliferating tumour
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cells and whether these have retained the
characteristics of the grafted tumour tissue.
Materials and methods
Animals and tumours
B6D2Fl mice, 6-12 weeks old, were used as
host animals for the subrenal grafts. They were
housed in plastic cages and were allowed free access
fo food pellets and tap water. There was a 12h
light-dark cycle. Nude, athymic mice (BALB/c
background) were purchased from the Laboratory
Breeding and Research Centre, GI. Bomholtgaard,
Ry, Denmark. They were housed in laminar air
flow rooms at constant temperature (24-26°C) and
humidity (60-70%). The cages, bedding, and water
were sterilized by autoclaving and the food by
gamma irradiation.
Human tumour lines maintained by serial
transplantation in nude, athymic mice (NMRI or
BALB/c strain) were used. The majority of the
lines had been established in this laboratory from
biopsies of patients at the Norwegian Radium
Hospital, except the colon tumours, Co-115 and
WiDr. The Co-115 was obtained from Dr B. Sordat,
Ch. ISREC, Epalinges/Lausanne, Switzerland, and
the WiDi was obtained from American Type
Culture Collection 12301, Parklawn Drive, Rockville,
Maryland 20852, USA. The tumour lines inblude
9 different malignant melanomas, 9 soft tissue
sarcomas, 1 osteogenic sarcoma, 2 colon-, 4 lung-,
and 2 mammary carcinomas.
Tumour implantation
Implantation of tumour tissue under the renal
capsule was carried out essentially as described by
Bogden et al. (1978). Subcutaneous tumours, 6-
15mm, were removed from the athymic mice and
immediately placed in RPMI medium at room
temperature. In the case of the larger tumours
(>10mm diameter), where the central parts
frequently contained necrotic tissue, viable tissue
was dissected out and placed in a separate Petri
dish. The tissue pieces, while immersed in the
medium, were cut by scalpels into cubes of
1 mm3.
The host animals (several groups of 5-10 animals
in each experiment) were anaesthetized by i.p.
injection of chloral hydrate (0.35-0.45ml of a
0.22moll-1 solution). The incision was made in the
left flank, and the kidney was exteriorized by
pulling in the peri-renal fat pad. A shallow incision,
- 3 mm long, was made on the convex side of the
kidney near the caudal pole. The tissue fragment
was implanted (one xenograft in each animal)
below the transparent capsule by means of a small
trochar (1.2mm bore). Immediately after
implantation, the tumour size was measured as
described below. The abdominal wall was closed
with sutures, whereas the skin was closed with clips.
To avoid hypothermia after the anaesthesia, the
animals were kept under an infrared lamp for
about an hour, and were then placed in the cages
under a blanket. By taking these precautions,
usually all animals survived.
S.c. implantation of tumour tissues in athymic,
nude mice was carried out as described by Fodstad
et al. (1980).
Evaluation oftutmour size
In the studies of the subrenal grafts the size of the
tumour was measured immediately after
implantation by using a stereoscopic microscope,
fitted with an ocular micrometer, calibrated in
ocular units (OMU) (1OOMU=1 mm). Two
perpendicular diameters were measured. At the end
of the experiment, usually after 6 days, the animals
were sacrifised by halothan, the kidney was
removed and the grafts were again measured in situ.
The difference in mean tumour diameter during the
growth period was calculated.
The size of the s.c. tumours in athymic nude mice
was measured twice weekly by calipers (2 vertical
diameters) as described by Fodstad et al. (1980).
All implantations and evaluations of grafts were
carried out by one of the authors (S.A.).
Immunosuppression
In some cases the mice were immunosuppressed by
administration of 200mgkg- cyclophosphamide
(Farmos Group, Turku, Finland) into the tail vein
24h before implantation of the grafts.
Isoenzyme studies
Samples from the xenografts were sonicated in
10mM sodium phosphate (pH 7.4) in 0.14M NaCl
for 45 s in an MSE ultrasonic power unit and
centrifuged at 2500g for 30min. The electrophoresis
was carried out as described by Meera Khan (1971)
on cellulose acetate gel (Cellogel; Chemetron
Chemicals, Milan, Italy).
Histological examination
The kidney with the graft was fixed in 4%
formaldehyde in phosphate buffer, and paraffin
sections were stained with haematoxylin and eosin.
Staining for melanin was carried out according to
Fontana-Masson and for mucin with Alciangreen.
Photomicrographs were made in a Zeiss
Photomicroscope III, using Ilford Pan F 50 ASA
film and green filter.SUBRENAL HUMAN GRAFTS IN IMMUNOCOMPETENT MICE 349
Estimation ofmitotic activity
In several sections from each xenograft all mitoses
present were recorded. In each case at least 1,000
tumour cells were counted.
Immunohistochemical studies
Carcino-embryonic antigen (CEA) was visualized in
tissue sections fixed in ice cold 96% ethanol. The
sections were incubated with tetramethyl-
rhodamine isothiocyanate (TRITC)-labeled rabbit
IgG anti-CEA conjugate (Rognum et al., 1980),
and subsequently, to enhance the red signal,
incubated with TRITC-labeled swine anti-rabbit
IgG. The observations were done in a Leitz
Orthoplan fluorescence microscope equipped with
an Osram HBO 200W lamp. Narrow-band
excitation and selective filtration of fluorescence
colours were obtained with a Ploem-type epi-
illuminator.
Human cells were distinguished from mouse cells
by an immunohistochemical method specific for
human cells. Formalin-fixed tissue sections were
incubated with rabbit anti-human IgG and
subsequently with horse-radish peroxidase (HRP)-
labeled swine anti-rabbit IgG obtained from
DAKO-Immunoglobulins A/S Copenhagen,
Denmark. The anti-human antibody was produced
in rabbits by repeated s.c. injections of 2 x 107
human leukocytes, dissolved the first time in
Freund's incomplete adjuvant and later in NaCI.
Neighbouring section were always stained with
Hematoxylin and Eosin.
Electron microscopy
Tissues for electron microscopy were fixed in
McDowell's solution (McDowell & Trump, 1976),
postfixed in osmium tetroxide, dehydrated in
graded alcohols and embedded in an Epon-Araldite
mixture. Semi-thin sections stained with toluidine
blue were used for light-microscopic examination.
Ultra-thin sections were cut with diamond knives,
mounted on naked copper grids, stained with
uranyl acetate and lead citrate and examined in the
transmission electron microscope.
Tissue for scanning electron microscopy were
critical-point dried, mounted on metal stubs and
sputter-coated with gold.
Titration ofanti-melanoma antibodies
The content of anti-melanoma antibody in the
serum of mice after tumour implantation was
measured by an enzyme-linked immunosorbant
assay (ELISA), essentially as described by Godal et
al. (1983), using as antigen an extract from a
human malignant melanoma, LOX. The antigen
was prepared as described by Watson et al. (1975).
Growth in soft agar
The xenografts were disaggregated to form single
cell suspensions, and cloning in soft agar was
carried out as described by Tveit & Pihl (1981).
Results
Growth
All tumours studied, except one, increased in size
during the 6-day period after transplantation under
the renal capsule. The tumours were usually paler
than the surrounding kidney tissue and clearly
protruding. In most cases the borderline of the
graft was not difficult to discern. A typical macro-
scopic picture of a subrenal graft is seen in Figure
1.
Figure 1 A subrenal graft, a human malignant melanoma, observed 6 days after transplantation. The mean
diameter of the tumour was more than twice that of the grafted piece.350 S. AAMDAL et al.
The different tumours grew reproducibly and
with individual characteristic rates (Aamdal et al.,
1984b). Typical examples are shown in Figure 2,
demonstrating the growth of 2 different soft tissue
sarcomas.
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Figure 2 Growth curves for 2 subrenal grafts, NFSX,
a neurofibrosarcoma (@) and RDX, a malignant
fibrous histiocytoma (A). The tumours, maintained by
serial s.c. transplantation in athymic mice, were
grafted under the kidney capsule of 15 immuno-
competent mice. At Days 2, 4 and 6, 5 animals were
sacrificed and the size of the tumours measured in situ,
as described in Materials and methods.
Morphological characteristics
Several histological sections were taken from all
grafts. They showed that on Day 6 the grafts
consisted primarily of tumour tissue with areas
containing small cells of mouse origin (see below).
In a few grafts central necrotic areas were found,
but by and large granulation tissue and necrosis
were not predominant features. Mitoses were
detected in all tumours, except one (a malignant
Schwannoma, MSX), showing that the tumour cells
were proliferating.
To evaluate the proliferative activity of the
tumour cells, the number of mitoses on Days 2, 4
and 6 were counted in several subrenal grafts fron
different tumours. The results in Table I show
significant mitotic activity in all the 8 tumours
studied in detail. In fact, in 5/8 cases the mitotic
index in the subrenal graft on Day 4 was
significantly higher (P<0.03) than in the original
xenograft. Also it is seen that in all cases the
mitotic index decreased from Day 4 to Day 6. The
decrease, possibly due to host immune reactions,
was significant (P<0.04) in 7/8 cases.
Histological sections of the subrenal grafts on
Day 6 were compared with sections of the
corresponding subcutaneous tumours in nude mice.
In Figure 3 histological sections are shown of an
amelanotic malignant melanoma, grown in nude
mice and of the corresponding subrenal tumours on
Day 6. Comparison of the sections before and after
growth under the renal capsule shows that the
subrenal graft contained undifferentiated polygonal
cells with abundant cytoplasm, a picture almost
identical with that of the original tumour. In a
melanotic melanoma, Fontana-Masson staining for
melanine was positive both in the original xenograft
and after growth for 6 days under the renal capsule
(Aamdal et al., 1984c).
Table I Mitotic activity in grafts
Mitotic indexa (±s.d.) in
Graft under the kidney capsule at
Tumour Original xenograft Day 2 Day 4 Day 6
Melanoma (LOX) 0.5+0.1 2.5+0.4 4.4+0.7 1.2+0.5
Melanoma (THX) 5.0+0.3 5.3+0.2 12.1+3.6 5.2+1.0
Melanoma (SSX) 3.8+0.3 3.4+0.2 0.8+0.2
Colon carcinoma (Co-115) 2.2+0.5 2.4+ 1.2 2.7+0.4 1.8+0.2
Colon carcinoma (WiDr) 4.4+0.9 5.9+0.9 7.4+2.2 4.6+1.1
Sarcoma (ASX) 3.8+ 1.7 4.3+0.6 6.7+ 1.5 2.4+0.4
Sarcoma (TPX) 5.3+1.3 3.2+0.6 7.2+1.0 0.7+0.2
Sarcoma (NFSX) 4.2+1.1 10.6+1.6 9.6+1.4 3.8+1.0
aNumber of mitoses in percent of total cells counted. A minimum of 1,000 cells was
counted in each case. The mitotic index in the grafts 4 days after implantation was higher
than in the original xenograft (t-test; P<0.0000, P=0.12, P=0.009, P=0.02, P=0.18,
P=0.15, P=0.15, P=0.03, P=0.01).
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A subrenal graft from a soft tissue sarcoma
showed the same typical storey-form patterns and
whirls as the subcutaneous xenograft (Figure 4).
The subrenal graft from a colon carcinoma
contained areas with clearly recognizable glandular
structures (Figure 5). Staining with Alcian green
demonstrated that the glands contained mucin (not
shown).
Figure 3 Histological sections of a human malignant melanoma, SSX, before (left panel) and 6 days after
(right panel) implantation under the renal capsule ofimmunocompetent mice. (H & E x 620).
Figure 4 Histological sections of a soft tissue sarcoma, a malignant fibrous histiocytoma, ASX, before (left
panel) and 6 days after (right panel) implantation under renal capsule of immunocompetent mice (H & E
x 390).
Figure 5 Histological sections of a colon carcinoma, WiDr, before (left panel) and 6 days after (right panel)
implantation under the renal capsule of immunocompetent mice. (H & E x 390).352 S. AAMDAL et al.
One of our colon carcinomas, WiDr, produced
CEA when it was growing s.c. in nude mice. In this
case the presence of CEA could be demonstrated in
the subrenal graft by an immuno-histochemical
method (not shown).
Electron microscopic examination of the subrenal
grafts revealed that the typical features of the
tumour types had been retained. Examples of easily
recognizable characteristics are shown in Figures 6
and 7 showing diagnostic premelanosomes in a
malignant melanoma (Figure 6) and epithelial cells
with microvilli in a colon carcinoma (Figure 7).
Altogether, the results indicate that human
tumours transplanted under the renal capsule of
Figure 6 Transmission electron micrographs of a malignant melanoma, EMX. Premelanosomes and
melanosomes are seen in the cytoplasm. UA/LC x 13,200.
Figure 7 Electron micrographs of a colon adenocarcinoma xenograft, WiDr. Secretory material is present in
the intercellular lumina (asterix). Cells bordering the lumen are well equipped with microvilli (UA/LC x 6,440).
Inset: Scanning electron micrograph of tumour cells with evenly distributed microvilli ( x 2,500).
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immunocompetent mice retain the morphological
and functional characteristics of the original
xenografts.
Host immune response
The histological sections contained areas with small
cells that were clearly different from the tumour
cells and that were absent in the xenografts grown
in the athymic mice. The morphological appearance
of the cells, as well as their presence primarily at or
near the rim (Figure 8, left panel), indicated that
they were inflammatory mouse cells in agreement
with previous findings (Edelstein et al., 1983;
Aamdal et al., 1984b, c). The mouse origin of these
cells follows from the fact that they were not
stained by peroxidase in an immunohistochemical
method specific for human cells (not shown).
Moreover, lactic dehydrogenase iso-enzyme patterns
studied in 11 different tumours showed typical
mouse bands in addition to the human bands (data
not shown). Faint mouse bands were present also
in the xenografts taken from the athymic mice, but
these bands were clearly more evident in the
subrenal grafts.
Since it was assumed by Bogden et al. (1978) that
host immune reactions do not become significant
until Day 9, it was of interest to follow the time
course of appearance of the infiltrating mouse cells.
Sections taken on days 2, 3 and 4 of 9 different
tumours (5 animals in each group) showed that the
infiltration actually started already on Day 4, and
became progressively evident with time (not
shown). In the case of 15 different tumours the
mice were pretreated with the strong immune-
suppressive agent cyclophosphamide, CY. In these
grafts the small cells failed to appear (Figure 8,
right panel), supporting the view that they represent
a cell-mediated response to the human cells.
In mice carrying a melanoma, LOX, a humoral
response could also be demonstrated on Day 3 and
later (Figure 9). Thus, with an ELISA method
employing a rabbit anti-human IgG antibody, it
was found that the titre of anti-human antibody
was significant already on Day 3 and subsequently
increased rapidly.
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Figure 9 Antibody response in mice with a subrenal
human melanoma graft, LOX. Blood samples were
drawn on the days indicated. Each value represents the
mean of observations on 3 mice. (Values obtained in
sham-operated control animals subtracted).
Tumourigenic capacity
In order to see whether the tumour cells of the
subrenal grafts had retained their malignant
character, their ability to form colonies in soft agar
and to form tumours in athymic, nude mice was
examined. Single cell suspensions of the grafts,
Figure 8 Infiltration of subrenal xenograft by mouse cells. Sections taken from the rim of a human
osteogenic sarcoma, TPX. Left panel, no pretreatment,; right panel, host animals pretreated with 200mgkg-I
of Cy on the day before implantation of the graft. (H & E x 156).
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taken on Day 6 gave rise to colonies in 7/9 cases
studied (not shown).
When the grafts were removed from the kidneys
and implanted s.c. in athymic, nude hosts (5 grafts
for each tumour tested), out of the 12 different
tumours studied altogether 10 grew subcutaneously
in the new hosts (6 malignant melanomas, 2 colon
carcinomas and 2 sarcomas).
In some instances we had occasion to measure
the growth rates of the grafts after re-implantation
in athymic mice. It was found that the tumours
grew subcutaneously with tumour volume doubling
times that were not statistically different from those
observed before passage under the renal capsule
(P<0.6), indicating that the tumours had retained
their characteristic growth rates (data not shown).
Discussion
The use of human tumour xenografts in chemo-
therapy studies is based on the premise that the
transplanted human tumour cells retain important
properties, including their chemosensitivity, when
growing in the foreign host. Although it can not be
excluded that some selection occurs when human
tumours are transplanted into athymic, nude mice,
there is considerable evidence that upon subsequent
serial transplantation they maintain their properties
and that they generally reflect rather well the
chemosensitivity of the parent tumours (Sordat et
al., 1974; Povlsen & Jacobsen, 1975; Houghton &
Taylor, 1978; Nowak et al., 1978; Shorthouse et al.,
1980; Giuliani et al., 1981; Steel et al., 1983). For
this reason s.c. growth of human tumours in
athymic mice has been used as a reference system
for other assays of chemosensitivity (Tveit et al.,
1982; Aamdal et al., 1983a, 1984b). However,
evidence that human tumour xenografts
transplanted under the renal capsule of
immunocompetent mice retain their properties had
not been presented.
It was found here, in agreement with our
previous findings (Aamdal et al., 1984a, 1984b,
1984c), that a variety of xenografts from different
human tumour lines was capable of growing well
under the renal capsule of conventional mice,
supporting the view that the conditions under the
renal capsule of mice are favourable for growth of
human tumours (Bogden et al., 1979).
Several lines of evidence indicated that the
subrenal grafts retain morphological and functional
characteristics during the assay period of 6 days.
Thus, after 6 days under the renal capsule the
tumour tissue resembled closely the xenograft of
origin. Proliferating tumour tissue with numerous
mitoses and little or no necrosis was found. In the
instances where characteristic substances could be
demonstrated, the tumour tissue retained the ability
to produce these substances after growth under the
renal capsule.
Of particular significance is our demonstration
that the grafted tumour cells had retained their
malignant growth potential after 6 days under the
kidney capsule. This follows from the demon-
stration that they were able to form colonies in soft
agar and s.c. tumours in athymic mice. The
tumours formed had growth rates that were closely
similar to those of the original xenografts in
athymic mice, indicating that the subrenal tumours
present after 6 days were representative of the
original s.c. xenografts and were not derived from a
selected subpopulation of the tumour cells.
Our results differ from those of Edelstein et al.
(1983) and Seltzer et al. (1983) who reported that
subrenal human grafts consisted mainly of oedema,
inflammatory cells, granulation tissue and necrotic
tissue. Part of the discrepancy may be due to the
fact that we have used serially transplanted and
fairly rapidly growing tumours whereas these
authors largely used surgical specimens directly
from patients. However, this can hardly account for
the whole difference as Edelstein et al. (1983)
studied xenografted tissue as well. Obviously, it is
essential that only viable tissue is grafted. In our
hands the results improved markedly with
experience over a period of several years.
The assumption that the cell-mediated responses
to a heterograft does not become evident until after
the 6-day observation period (Bogden et al., 1979)
has not been confirmed (Edelstein et al., 1983;
Aamdal et al., 1984b). The present results show that
an immune response may appear already after a
few days. Thus, antibodies directed against the
transplanted human tissue could be detected
already on Day 3, and the infiltration of the graft
by host cells was seen already on Day 4.
The infiltration of the subrenal grafts by host
cells is a potential source of error in the measure-
ment of the growth of the tumour tissue. However,
in a separate study (Aamdal et al., 1984b) where
the contribution of the mouse cells to the total
graft volume was quantified, it was found that in
these tumour lines, the mouse cell infiltration did
not significantly affect the growth of the grafts
during the 6-day observation period.
The present study is part of an extensive
investigation of the 6-day SRC assay and its merits
compared to other procedures used for studying the
response of human cancer cells to cytostatic drugs.
In other papers we have reported that the chemo-
sensitivity of several human tumour xenografts was
closely similar when tested in the 6-day SRC and in
the athymic, nude mouse model (Aamdal et al.,SUBRENAL HUMAN GRAFTS IN IMMUNOCOMPETENT MICE 355
1983a, 1984c, 1984d). Altogether these results,
which recently have been confirmed in more
extensive studies (to be published), provide evidence
that human tumour lines transplanted under the
kidney capsule of conventional mice may be a
useful system for screening of new chemothera-
peutic drugs. Further studies on specimens obtained
directly from patients are required to establish the
validity of the 6-day SRC assay as a method for
predicting the chemosensitivity of individual human
tumours.
The authors are indebted to Dr A. Godal for carrying out
the titration of anti-human antibody and to Dr T.
Rognum, Department of Pathology, The National
Hospital, Oslo, for carrying out the cytochemical
demonstration of CEA. We wish to thank Ruth Holm,
M.Sc., for help with the immunohistochemical staining.
The excellent technical assistance of Unni Rbnning and
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